Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00522223 · ClinicalTrials.gov registry record
Sexual Functioning in Cervical Cancer Survivors
A clinical trial, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- 111
- Enrollment target
NCT00522223: Completed study, sponsored by M.D. Anderson Cancer Center.
NCT00522223 is a clinical trial that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 111 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00522223 has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- 111 participants
- Enrollment target
Study Summary
Objectives: Primary Objectives: To assess the entire range of sexual functioning (desire, arousal, orgasmic capacity, dyspareunia, and sexual satisfaction) over the course of treatment and early follow-up in patients with local and locally advanced cervical cancer; To assess general cancer-related QOL over the course of treatment and early follow-up in patients with local and locally advanced cervical cancer; To characterize the relationship between sexual dysfunction and overall cancer-related QOL over time; and To identify factors that may predict better sexual function outcomes in patients treated for cervical cancer. Secondary Objectives: Describe vaginal changes objectively via measurement of vaginal length. Demonstrate reliability of the vaginal length instrument and its applicability to future studies.
Interventions
- BEHAVIORAL Questionnaire
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 111 participants |
| Start Date | 2002-09-10 |
| Est. Completion | 2018-06-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00522223
The ClinicalTrials.gov registry entry for NCT00522223 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 111 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Questionnaire is the first listed.
NCT00522223 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00522223 about?
NCT00522223 is a clinical study titled "Sexual Functioning in Cervical Cancer Survivors". Objectives: Primary Objectives: To assess the entire range of sexual functioning (desire, arousal, orgasmic capacity, dyspareunia, and sexual satisfaction) over the course of treatment and early follow-up in patients with local and locally advanced cervical cancer; To assess general cancer-related...
What is the current status of trial NCT00522223?
This trial is currently completed. The enrollment target is 111 participants. The study started on 2002-09-10. Estimated completion is 2018-06-08.
What interventions are being tested in trial NCT00522223?
The interventions under investigation include: Questionnaire (BEHAVIORAL).
Who is sponsoring clinical trial NCT00522223?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.